经济模型中专家意见的恰当引出：使专家数据适用于特定目的。 - Suppr

Suppr

超能文献

The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.

作者信息

Sullivan William, Payne Katherine

机构信息

ScHARR, The University of Sheffield, Sheffield, South Yorkshire, UK.

出版信息

Pharmacoeconomics. 2011 Jun;29(6):455-9. doi: 10.2165/11589220-000000000-00000.

DOI:10.2165/11589220-000000000-00000

PMID:21568356

Abstract

摘要

相似文献

The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.

Pharmacoeconomics. 2011 Jun;29(6):455-9. doi: 10.2165/11589220-000000000-00000.

Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Pharmacoeconomics. 2016 Nov;34(11):1161-1172. doi: 10.1007/s40273-016-0425-9.

A comparison of two methods for expert elicitation in health technology assessments.

BMC Med Res Methodol. 2016 Jul 26;16:85. doi: 10.1186/s12874-016-0186-3.

An expert on every street corner? Methods for eliciting distributions in geographically dispersed opinion pools.

Value Health. 2013 Mar-Apr;16(2):434-7. doi: 10.1016/j.jval.2012.10.011. Epub 2013 Jan 29.

The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Med Decis Making. 2022 Jul;42(5):684-703. doi: 10.1177/0272989X211053794. Epub 2021 Oct 25.

EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.

BMC Med Inform Decis Mak. 2017 Sep 4;17(1):131. doi: 10.1186/s12911-017-0527-0.

Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.

Clin Trials. 2017 Aug;14(4):357-367. doi: 10.1177/1740774517711442. Epub 2017 Jul 4.

Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology.

Med Decis Making. 2025 Jul;45(5):602-613. doi: 10.1177/0272989X251332967. Epub 2025 Apr 25.

Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.

Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.

Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Pharmacoeconomics. 2017 Sep;35(9):867-877. doi: 10.1007/s40273-017-0525-1.

引用本文的文献

Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review.

Pharmacoeconomics. 2023 Jun;41(6):675-692. doi: 10.1007/s40273-022-01234-7. Epub 2023 Mar 11.

Where is genetic medicine headed? Exploring the perspectives of Canadian genetic professionals on future trends using the Delphi method.

Eur J Hum Genet. 2022 May;30(5):496-504. doi: 10.1038/s41431-021-01017-2. Epub 2022 Jan 15.

Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.

Med Decis Making. 2022 May;42(4):538-553. doi: 10.1177/0272989X211053792. Epub 2021 Oct 25.

Health and economic outcomes of newborn screening for infantile-onset Pompe disease.

Genet Med. 2021 Apr;23(4):758-766. doi: 10.1038/s41436-020-01038-0. Epub 2020 Dec 7.

Structuring a conceptual model for cost-effectiveness analysis of frailty interventions.

PLoS One. 2019 Sep 11;14(9):e0222049. doi: 10.1371/journal.pone.0222049. eCollection 2019.

Incremental cost and health gains of the 2016 WHO antenatal care recommendations for Rwanda: results from expert elicitation.

Health Res Policy Syst. 2019 Apr 5;17(1):36. doi: 10.1186/s12961-019-0439-9.

Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.

MDM Policy Pract. 2018 Jan-Jun;3(1). doi: 10.1177/2381468318763814. Epub 2018 Apr 18.

A Bayesian framework for health economic evaluation in studies with missing data.

Health Econ. 2018 Nov;27(11):1670-1683. doi: 10.1002/hec.3793. Epub 2018 Jul 3.

Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Pharmacoeconomics. 2017 Sep;35(9):867-877. doi: 10.1007/s40273-017-0525-1.

How Qualitative Methods Can be Used to Inform Model Development.

Pharmacoeconomics. 2017 Jun;35(6):607-612. doi: 10.1007/s40273-017-0499-z.

本文引用的文献

Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.

Br J Cancer. 2010 Jul 27;103(3):315-23. doi: 10.1038/sj.bjc.6605766.

Fish and chips all round? Regulation of DNA-based genetic diagnostics.

Health Econ. 2009 Nov;18(11):1233-6. doi: 10.1002/hec.1553.

Characterizing structural uncertainty in decision analytic models: a review and application of methods.

Value Health. 2009 Jul-Aug;12(5):739-49. doi: 10.1111/j.1524-4733.2008.00502.x.

Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.

Int J Technol Assess Health Care. 2008 Fall;24(4):459-64. doi: 10.1017/S0266462308080604.

Subgroups and heterogeneity in cost-effectiveness analysis.

Pharmacoeconomics. 2008;26(9):799-806. doi: 10.2165/00019053-200826090-00009.

The value of implementation and the value of information: combined and uneven development.

Med Decis Making. 2008 Jan-Feb;28(1):21-32. doi: 10.1177/0272989X07308751.

Value based pricing for NHS drugs: an opportunity not to be missed?

BMJ. 2008 Feb 2;336(7638):251-4. doi: 10.1136/bmj.39434.500185.25.

A critique and impact analysis of decision modeling assumptions.

Med Decis Making. 2007 Jul-Aug;27(4):491-9. doi: 10.1177/0272989X07300606.

Eliciting expert opinion for economic models: an applied example.

Value Health. 2007 May-Jun;10(3):195-203. doi: 10.1111/j.1524-4733.2007.00169.x.

Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.

Pharmacoeconomics. 2006;24(4):355-71. doi: 10.2165/00019053-200624040-00006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.

作者信息

Sullivan William, Payne Katherine

机构信息

ScHARR, The University of Sheffield, Sheffield, South Yorkshire, UK.

出版信息

Pharmacoeconomics. 2011 Jun;29(6):455-9. doi: 10.2165/11589220-000000000-00000.

DOI:10.2165/11589220-000000000-00000

PMID:21568356

Abstract

摘要

相似文献

The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.

Pharmacoeconomics. 2011 Jun;29(6):455-9. doi: 10.2165/11589220-000000000-00000.

Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Pharmacoeconomics. 2016 Nov;34(11):1161-1172. doi: 10.1007/s40273-016-0425-9.

A comparison of two methods for expert elicitation in health technology assessments.

BMC Med Res Methodol. 2016 Jul 26;16:85. doi: 10.1186/s12874-016-0186-3.

An expert on every street corner? Methods for eliciting distributions in geographically dispersed opinion pools.

Value Health. 2013 Mar-Apr;16(2):434-7. doi: 10.1016/j.jval.2012.10.011. Epub 2013 Jan 29.

The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Med Decis Making. 2022 Jul;42(5):684-703. doi: 10.1177/0272989X211053794. Epub 2021 Oct 25.

EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.

BMC Med Inform Decis Mak. 2017 Sep 4;17(1):131. doi: 10.1186/s12911-017-0527-0.

Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.

Clin Trials. 2017 Aug;14(4):357-367. doi: 10.1177/1740774517711442. Epub 2017 Jul 4.

Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology.

Med Decis Making. 2025 Jul;45(5):602-613. doi: 10.1177/0272989X251332967. Epub 2025 Apr 25.

Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.

Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.

Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Pharmacoeconomics. 2017 Sep;35(9):867-877. doi: 10.1007/s40273-017-0525-1.

引用本文的文献

Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review.

Pharmacoeconomics. 2023 Jun;41(6):675-692. doi: 10.1007/s40273-022-01234-7. Epub 2023 Mar 11.

Where is genetic medicine headed? Exploring the perspectives of Canadian genetic professionals on future trends using the Delphi method.

Eur J Hum Genet. 2022 May;30(5):496-504. doi: 10.1038/s41431-021-01017-2. Epub 2022 Jan 15.

Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.

Med Decis Making. 2022 May;42(4):538-553. doi: 10.1177/0272989X211053792. Epub 2021 Oct 25.

Health and economic outcomes of newborn screening for infantile-onset Pompe disease.

Genet Med. 2021 Apr;23(4):758-766. doi: 10.1038/s41436-020-01038-0. Epub 2020 Dec 7.

Structuring a conceptual model for cost-effectiveness analysis of frailty interventions.

PLoS One. 2019 Sep 11;14(9):e0222049. doi: 10.1371/journal.pone.0222049. eCollection 2019.

Incremental cost and health gains of the 2016 WHO antenatal care recommendations for Rwanda: results from expert elicitation.

Health Res Policy Syst. 2019 Apr 5;17(1):36. doi: 10.1186/s12961-019-0439-9.

Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.

MDM Policy Pract. 2018 Jan-Jun;3(1). doi: 10.1177/2381468318763814. Epub 2018 Apr 18.

A Bayesian framework for health economic evaluation in studies with missing data.

Health Econ. 2018 Nov;27(11):1670-1683. doi: 10.1002/hec.3793. Epub 2018 Jul 3.

Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Pharmacoeconomics. 2017 Sep;35(9):867-877. doi: 10.1007/s40273-017-0525-1.

How Qualitative Methods Can be Used to Inform Model Development.

Pharmacoeconomics. 2017 Jun;35(6):607-612. doi: 10.1007/s40273-017-0499-z.

本文引用的文献

Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.

Br J Cancer. 2010 Jul 27;103(3):315-23. doi: 10.1038/sj.bjc.6605766.

Fish and chips all round? Regulation of DNA-based genetic diagnostics.

Health Econ. 2009 Nov;18(11):1233-6. doi: 10.1002/hec.1553.

Characterizing structural uncertainty in decision analytic models: a review and application of methods.

Value Health. 2009 Jul-Aug;12(5):739-49. doi: 10.1111/j.1524-4733.2008.00502.x.

Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.

Int J Technol Assess Health Care. 2008 Fall;24(4):459-64. doi: 10.1017/S0266462308080604.

Subgroups and heterogeneity in cost-effectiveness analysis.

Pharmacoeconomics. 2008;26(9):799-806. doi: 10.2165/00019053-200826090-00009.

The value of implementation and the value of information: combined and uneven development.

Med Decis Making. 2008 Jan-Feb;28(1):21-32. doi: 10.1177/0272989X07308751.

Value based pricing for NHS drugs: an opportunity not to be missed?

BMJ. 2008 Feb 2;336(7638):251-4. doi: 10.1136/bmj.39434.500185.25.

A critique and impact analysis of decision modeling assumptions.

Med Decis Making. 2007 Jul-Aug;27(4):491-9. doi: 10.1177/0272989X07300606.

Eliciting expert opinion for economic models: an applied example.

Value Health. 2007 May-Jun;10(3):195-203. doi: 10.1111/j.1524-4733.2007.00169.x.

Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.

Pharmacoeconomics. 2006;24(4):355-71. doi: 10.2165/00019053-200624040-00006.